Home - Products - Others - Other Targets - IELLQAR (8 - branch MAPS) Selectin Binding Peptide

IELLQAR (8 - branch MAPS) Selectin Binding Peptide

CAS No. ———

IELLQAR (8 - branch MAPS) Selectin Binding Peptide( ——— )

Catalog No. M41811 CAS No. ———

IELLQAR (8 - branch MAPS) Selectin Binding Peptide

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    IELLQAR (8 - branch MAPS) Selectin Binding Peptide
  • Note
    Research use only, not for human use.
  • Brief Description
    IELLQAR (8 - branch MAPS) Selectin Binding Peptide
  • Description
    IELLQAR (8 - branch MAPS) Selectin Binding Peptide
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    842.01
  • Molecular Formula
    C37H67N11O11
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Meranzin

    Meranzin is an absorbed bioactive compound from the Traditional Chinese Medicine (TCM) Chaihu-Shugan-San (CSS).?

  • HLM006474

    HLM006474 is a pan inhibitor of E2F. This inhibits E2F4 DNA-binding (IC50: 29.8 μM in A375 cells).HLM006474 causes the viability of both SCLC and NSCLC lines (IC50 ranging from 15 to 75 μM). HLM006474 displays little activities against E2F4 DNA-binding in A375 cells at 10 and 20 μM, apparently inhibits E2F4 DNA-binding at 40 μM, and increasingly suppresses the effect at 60 and 80 μM concentrations.

  • Acetyl shikonin

    Acetylshikonin exhibits weak cytotoxicity against human umbilical vein endothelial cells (HUVECs) with IC5 of over 2 microM, exhibits the antiangiogenic and antitumorigenic effects by suppressing proliferation and angiogenic factors.